These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30365389)

  • 21. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personal and ambient exposures to air toxics in Camden, New Jersey.
    Lioy PJ; Fan Z; Zhang J; Georgopoulos P; Wang SW; Ohman-Strickland P; Wu X; Zhu X; Harrington J; Tang X; Meng Q; Jung KH; Kwon J; Hernandez M; Bonnano L; Held J; Neal J;
    Res Rep Health Eff Inst; 2011 Aug; (160):3-127; discussion 129-51. PubMed ID: 22097188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure Load: Using biomonitoring data to quantify multi-chemical exposure burden in a population.
    Willey JB; Pollock T; Thomson EM; Liang CL; Maquiling A; Walker M; St-Amand A
    Int J Hyg Environ Health; 2021 May; 234():113704. PubMed ID: 33690093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with the blood and urinary selenium concentrations in the Canadian population: Results of the Canadian Health Measures Survey (2007-2011).
    Hu XF; Chan HM
    Int J Hyg Environ Health; 2018 Aug; 221(7):1023-1031. PubMed ID: 30078419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of PK- and PBPK-based modeling tools for derivation of biomonitoring guidance values.
    Bartels M; Rick D; Lowe E; Loizou G; Price P; Spendiff M; Arnold S; Cocker J; Ball N
    Comput Methods Programs Biomed; 2012 Nov; 108(2):773-88. PubMed ID: 22704290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpreting biomonitoring data for 2,4-dichlorophenoxyacetic acid: Update to Biomonitoring Equivalents and population biomonitoring data.
    Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):765-9. PubMed ID: 26577196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomonitoring Equivalents (BE) dossier for toluene (CAS No. 108-88-3).
    Aylward LL; Barton HA; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S27-36. PubMed ID: 18583006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans.
    Tardif R; Charest-Tardif G; Brodeur J; Krishnan K
    Toxicol Appl Pharmacol; 1997 May; 144(1):120-34. PubMed ID: 9169076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human biomonitoring reference values for some non-persistent chemicals in blood and urine derived from the Canadian Health Measures Survey 2009-2013.
    Khoury C; Werry K; Haines D; Walker M; Malowany M
    Int J Hyg Environ Health; 2018 May; 221(4):684-696. PubMed ID: 29580848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human inhalation exposures to toluene, ethylbenzene, and m-xylene and physiologically based pharmacokinetic modeling of exposure biomarkers in exhaled air, blood, and urine.
    Marchand A; Aranda-Rodriguez R; Tardif R; Nong A; Haddad S
    Toxicol Sci; 2015 Apr; 144(2):414-24. PubMed ID: 25601989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomonitoring Equivalents for interpretation of silver biomonitoring data in a risk assessment context.
    Aylward LL; Bachler G; von Goetz N; Poddalgoda D; Hays SM; Nong A
    Int J Hyg Environ Health; 2016 Aug; 219(6):521-6. PubMed ID: 27283208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reconstructing exposures from biomarkers using exposure-pharmacokinetic modeling--A case study with carbaryl.
    Brown K; Phillips M; Grulke C; Yoon M; Young B; McDougall R; Leonard J; Lu J; Lefew W; Tan YM
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):689-98. PubMed ID: 26545325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a human Physiologically Based Pharmacokinetic (PBPK) Toolkit for environmental pollutants.
    Ruiz P; Ray M; Fisher J; Mumtaz M
    Int J Mol Sci; 2011; 12(11):7469-80. PubMed ID: 22174611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposed occupational exposure limits for select ethylene glycol ethers using PBPK models and Monte Carlo simulations.
    Sweeney LM; Tyler TR; Kirman CR; Corley RA; Reitz RH; Paustenbach DJ; Holson JF; Whorton MD; Thompson KM; Gargas ML
    Toxicol Sci; 2001 Jul; 62(1):124-39. PubMed ID: 11399800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene.
    Jonsson F; Johanson G
    Toxicology; 2001 Jan; 157(3):177-93. PubMed ID: 11164983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in environmental chemical concentrations in the Canadian population: Biomonitoring data from the Canadian Health Measures Survey 2007-2017.
    Pollock T; Karthikeyan S; Walker M; Werry K; St-Amand A
    Environ Int; 2021 Oct; 155():106678. PubMed ID: 34118655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation and modeling of the impact of coexposures to VOC mixtures on urinary biomarkers.
    Marchand A; Aranda-Rodriguez R; Tardif R; Nong A; Haddad S
    Inhal Toxicol; 2016; 28(6):260-73. PubMed ID: 27053005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes.
    Karrer C; Roiss T; von Goetz N; Gramec Skledar D; Peterlin Mašič L; Hungerbühler K
    Environ Health Perspect; 2018 Jul; 126(7):077002. PubMed ID: 29995627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human biomonitoring reference values derived for persistent organic pollutants in blood plasma from the Canadian Health Measures Survey 2007-2011.
    Haines DA; Khoury C; Saravanabhavan G; Werry K; Walker M; Malowany M
    Int J Hyg Environ Health; 2017 Jun; 220(4):744-756. PubMed ID: 28372942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using exposure prediction tools to link exposure and dosimetry for risk-based decisions: A case study with phthalates.
    Moreau M; Leonard J; Phillips KA; Campbell J; Pendse SN; Nicolas C; Phillips M; Yoon M; Tan YM; Smith S; Pudukodu H; Isaacs K; Clewell H
    Chemosphere; 2017 Oct; 184():1194-1201. PubMed ID: 28672700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.